Aquestive Therapeutics (AQST) Current Assets (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Current Assets of $130.2 million for Q1 2026, up 46.0% year-over-year from $89.2 million in Q1 2025, and down 12.79% quarter-over-quarter from $149.3 million in Q4 2025.
Aquestive Therapeutics (AQST) Current Assets (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Current Assets history runs 10 years deep, the most recent figure standing at $130.2 million for Q1 2026.
- In Q1 2026, Current Assets rose 46.0% year-over-year to $130.2 million; the TTM figure through Mar 2026 stood at $130.2 million (up 46.0% YoY), while the FY2025 annual figure was $149.3 million, up 69.2% from the prior year.
- Current Assets for Q1 2026 stood at $130.2 million, down from $149.3 million in the prior quarter.
- The five-year high for Current Assets was $151.7 million in Q3 2025, with the low at $38.1 million in Q3 2022.
- The 5-year median for Current Assets is $81.7 million (2025), against an average of $78.5 million.
- The sharpest annual moves came in 2022 and 2024: Current Assets retreated 24.14% in 2022, then soared 161.41% in 2024.
- Aquestive Therapeutics' Current Assets stood at $39.9 million in 2022, then grew by 2.7% to $41.0 million in 2023, then soared by 115.35% to $88.2 million in 2024, then jumped by 69.2% to $149.3 million in 2025, then declined by 12.79% to $130.2 million in 2026.
- Business Quant data shows AQST's Current Assets at $130.2 million in Q1 2026, $149.3 million in Q4 2025, and $151.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 3.22 Bn |
| 10 | Aquestive Therapeutics | 554.85 Mn | 554.85 Mn | 9.80 Mn | 118.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 118.49 Mn |
| Mar 31, 2026 | 130.18 Mn |
| Dec 31, 2025 | 149.27 Mn |
| Sep 30, 2025 | 151.67 Mn |
| Jun 30, 2025 | 81.72 Mn |
| Mar 31, 2025 | 89.17 Mn |
| Dec 31, 2024 | 88.22 Mn |
| Sep 30, 2024 | 96.57 Mn |
| Jun 30, 2024 | 104.01 Mn |
| Mar 31, 2024 | 113.38 Mn |
| Dec 31, 2023 | 40.97 Mn |
| Sep 30, 2023 | 42.46 Mn |
| Jun 30, 2023 | 39.79 Mn |
| Mar 31, 2023 | 43.71 Mn |
| Dec 31, 2022 | 39.89 Mn |
| Sep 30, 2022 | 38.09 Mn |
| Jun 30, 2022 | 43.51 Mn |
| Mar 31, 2022 | 42.59 Mn |
| Dec 31, 2021 | 47.26 Mn |
| Sep 30, 2021 | 50.21 Mn |